TechFlow news, October 6 — According to PRNewswire, NASDAQ-listed Leap Therapeutics announced it has entered into a securities purchase agreement to raise $58,888,888 through a private investment in public equity (PIPE), led by Winklevoss Capital. The transaction is expected to close on October 8. The company will use the proceeds to launch a digital asset treasury. Winklevoss Capital will have the right to nominate two individuals to Leap’s board of directors, one of whom will also serve as chairman of the board.
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




